First Horizon Advisors’s Altimmune ALT Stock Holding History

First Horizon Advisors’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$12	Hold	3	–	–	﹤0.01%	2312
2025 Q1	$15	Hold	3	–	–	﹤0.01%	2300
2024 Q4	$22	Hold	3	–	–	﹤0.01%	2263
2024 Q3	$18	Hold	3	–	–	﹤0.01%	2304
2024 Q2	$20	Hold	3	–	–	﹤0.01%	2275
2024 Q1	$31	Hold	3	–	–	﹤0.01%	2282
2023 Q4	$34	Hold	3	–	–	﹤0.01%	2355
2023 Q3	$8	Sell	3 -110	-97%	-$316	﹤0.01%	2379
2023 Q2	$399	Hold	113	–	–	﹤0.01%	2397
2023 Q1	$477	Buy	113 +110	+3,667%	+$1.31K	﹤0.01%	2397
2022 Q4	$49	Hold	3	–	–	﹤0.01%	2438
2022 Q3	$0	Hold	3	–	–	﹤0.01%	2260
2022 Q2	$0	Sell	3 -1,035	-100%	-$6.38K	﹤0.01%	2353
2022 Q1	$6K	Buy	1,038 +927	+835%	+$6.83K	﹤0.01%	1225
2021 Q4	$1K	Sell	111 -42	-27%	-$446	﹤0.01%	2059
2021 Q3	$1K	Buy	153 +111	+264%	+$1.35K	﹤0.01%	2071
2021 Q2	$0	Buy	+42	New	+$574	﹤0.01%	1956

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

First Horizon Advisors's ALT Position: Q2 2025 in Review

First Horizon Advisors held its Altimmune (ALT) position steady in Q2 2025 at 3 shares worth $12. The position accounts for ﹤0.01% of the portfolio, ranked #2312.

First Horizon Advisors first reported a position in ALT in Q2 2021 and has held it in 17 quarters since. The position peaked at $6K in Q1 2022. 180 funds tracked by Wall St. Rank hold ALT as of Q2 2025.

First Horizon Advisors held 3 shares of Altimmune worth $12 as of Q2 2025.
First Horizon Advisors left its Altimmune share count unchanged in Q2 2025.
Altimmune made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #2312 holding.
First Horizon Advisors first reported a position in Altimmune in Q2 2021 and has held it in 17 quarters since.
First Horizon Advisors's Altimmune position peaked at $6K in Q1 2022.
180 funds tracked by Wall St. Rank held Altimmune as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.